Raza Ur Rehman’s Commentary on Fitusiran for the Management of Hemophilia A and B To Be Published
Raza Ur Rehman, Bachelor of Medicine and Surgery at Shaikh Khalifa bin Zayed Al Nahyan Medical and Dental College, shared on LinkedIn:
”I am pleased to share that my commentary article on Fitusiran, a first-in-class RNA interference (RNAi) therapy for the management of Hemophilia A and Hemophilia B, has been accepted for publication in Health Science Reports (Wiley).
This commentary discusses the evolving role of Fitusiran in rebalancing hemostasis and highlights its clinical significance in the current and future landscape of hemophilia management.
I am grateful to the editorial team at Health Science Reports for their efficient handling of the manuscript and the opportunity to contribute to the scientific discourse in this field.”
Stay updated with Hemostasis Today.
-
Dec 22, 2025, 17:09Matteo Foschi Shares Review on Ischemic Stroke Despite Appropriate Oral Anticoagulation
-
Dec 22, 2025, 17:00Danny Hsu and Nicola Pozzi on “Tetra-Positive” APS
-
Dec 22, 2025, 16:44Jose Ricardo Soares: Genomic Testing for All Patients Considered for Clopidogrel in UK
-
Dec 22, 2025, 16:28Vikram Huded Shares The Thrombectomy Screening 3-6-24 Rule for Anterior Circulation Stroke
-
Dec 22, 2025, 16:18Timothy Glidewell on CosMx – A Promise for Severe Aplastic Anemia
-
Dec 22, 2025, 16:00Usman Waheed: Inauguration of the 6th Annual Conference of Bring Brilliant Minds of Transfusion
-
Dec 22, 2025, 15:30Wael Saad Presents His Portal Hypertension Book at Alma Mater
-
Dec 22, 2025, 15:05Maaike Wisse Honoured with Arthur Fonville Award
-
Dec 22, 2025, 10:24Be a Secret Santa – For a Child With Leukemia, a Mother in Childbirth, and a Stranger Who Wants Another Christmas